Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) studies medicines management for patients with heart failure across a range of health organisations involved in their care in the National Health Service (NHS). We are funded by the National Institute for Health Research (NIHR) through its Programme Grants for Applied Health Research. Our focus is on working with patients and healthcare staff to develop and test a Medicines at Transitions Toolkit (MaTT) to improve the management of medicines across care transitions (e.g. when patients move between hospital and home).
We are a multidisciplinary research collaboration between University of Bradford and University of Leeds involving academics, patients, the NHS and the NIHR Clinical Research Network.
The ISCOMAT study began in March 2016 and will last for 30 months in the first instance and, if our randomised cluster control trial (RCCT) is approved, a further 38 months.
The research is funded by the NIHR Programme Grants for Applied Research. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.